Literature DB >> 17261973

The genetic basis of neonatal diabetes mellitus.

Mark A Sperling1.   

Abstract

Neonatal diabetes mellitus is a rare condition occurring within the first few months of life that can either be permanent or transient. Various genetic defects responsible for both permanent and transient neonatal diabetes have been identified. ATP-sensitive potassium (KATP) channels are key regulators of nutrient-induced insulin secretion in pancreatic beta cells. Activating mutations of the KATP channel, which prevent closure of the channel and thus inhibit insulin secretion, are now known to be the predominant cause of permanent neonatal diabetes. Transient neonatal diabetes may also be associated with activating mutations of the KATP channel. However, the majority of cases of transient neonatal diabetes have a mutation that maps to a locus on the long arm of chromosome 6, and mutations in two overlapping genes, ZAC and HYMA1, have been identified as the predominant cause of transient neonatal diabetes. These findings provide important insights into the molecular and genetic basis in the broad spectrum of diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17261973

Source DB:  PubMed          Journal:  Pediatr Endocrinol Rev        ISSN: 1565-4753


  4 in total

1.  Secondary consequences of beta cell inexcitability: identification and prevention in a murine model of K(ATP)-induced neonatal diabetes mellitus.

Authors:  Maria Sara Remedi; Harley T Kurata; Alexis Scott; F Thomas Wunderlich; Eva Rother; Andre Kleinridders; Ailing Tong; Jens C Brüning; Joseph C Koster; Colin G Nichols
Journal:  Cell Metab       Date:  2009-02       Impact factor: 27.287

2.  Development and stability study of glibenclamide oral liquid paediatric formulations for the treatment of permanent neonatal diabetes mellitus.

Authors:  Pablo Estevez; Oriana Boscolo; Eduardo Quiroga; Rocio Fernandez Penuto; Fabian Buontempo; Valeria Tripodi; Silvia Lucangioli
Journal:  Eur J Hosp Pharm       Date:  2015-12-16

3.  Acute sulfonylurea therapy at disease onset can cause permanent remission of KATP-induced diabetes.

Authors:  Maria Sara Remedi; Sophia E Agapova; Arpita K Vyas; Paul W Hruz; Colin G Nichols
Journal:  Diabetes       Date:  2011-08-03       Impact factor: 9.461

4.  Diabetes induced by gain-of-function mutations in the Kir6.1 subunit of the KATP channel.

Authors:  Maria S Remedi; Jonathan B Friedman; Colin G Nichols
Journal:  J Gen Physiol       Date:  2016-12-12       Impact factor: 4.086

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.